These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27445695)

  • 41. Differential Somatic Ca2+ Channel Profile in Midbrain Dopaminergic Neurons.
    Philippart F; Destreel G; Merino-Sepúlveda P; Henny P; Engel D; Seutin V
    J Neurosci; 2016 Jul; 36(27):7234-45. PubMed ID: 27383597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced visual responses in the superior colliculus and subthalamic nucleus in an animal model of Parkinson's disease.
    Rolland M; Carcenac C; Overton PG; Savasta M; Coizet V
    Neuroscience; 2013 Nov; 252():277-88. PubMed ID: 23916713
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area.
    Chen BT; Rice ME
    J Neurochem; 2002 Apr; 81(1):158-69. PubMed ID: 12067228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered Synaptic and Extrasynaptic NMDA Receptor Properties in Substantia Nigra Dopaminergic Neurons From Mice Lacking the GluN2D Subunit.
    Morris PG; Mishina M; Jones S
    Front Cell Neurosci; 2018; 12():354. PubMed ID: 30364232
    [No Abstract]   [Full Text] [Related]  

  • 45. Fibroblast growth factor receptor signaling affects development and function of dopamine neurons - inhibition results in a schizophrenia-like syndrome in transgenic mice.
    Klejbor I; Myers JM; Hausknecht K; Corso TD; Gambino AS; Morys J; Maher PA; Hard R; Richards J; Stachowiak EK; Stachowiak MK
    J Neurochem; 2006 Jun; 97(5):1243-58. PubMed ID: 16524369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age.
    Costa G; Pinna A; Porceddu PF; Casu MA; Di Maio A; Napolitano F; Usiello A; Morelli M
    Front Aging Neurosci; 2018; 10():163. PubMed ID: 29904346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
    Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
    J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subsaturation of the N-methyl-D-aspartate receptor glycine site allows the regulation of bursting activity in juvenile rat nigral dopamine neurons.
    Destreel G; Seutin V; Engel D
    Eur J Neurosci; 2019 Nov; 50(9):3454-3471. PubMed ID: 31206829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons.
    Zhou ZD; Refai FS; Xie SP; Ng SH; Chan CH; Ho PG; Zhang XD; Lim TM; Tan EK
    Free Radic Biol Med; 2014 Mar; 68():220-33. PubMed ID: 24374372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A partial lesion of the substantia nigra pars compacta and retrorubral field decreases the harmaline-induced glutamate release in the rat cerebellum.
    Gołembiowska K; Berghauzen-Maciejewska K; Górska A; Kamińska K; Ossowska K
    Brain Res; 2013 Nov; 1537():303-11. PubMed ID: 24012623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulated ECM genes and increased synaptic activity in Parkinson's human DA neurons with PINK1/ PRKN mutations.
    Tripathi U; Rosh I; Ben Ezer R; Nayak R; Hussein Y; Choudhary A; Djamus J; Manole A; Houlden H; Gage FH; Stern S
    NPJ Parkinsons Dis; 2024 May; 10(1):103. PubMed ID: 38762512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats.
    Guatteo E; Rizzo FR; Federici M; Cordella A; Ledonne A; Latini L; Nobili A; Viscomi MT; Biamonte F; Landrock KK; Martini A; Aversa D; Schepisi C; D'Amelio M; Berretta N; Mercuri NB
    Exp Neurol; 2017 Jan; 287(Pt 1):21-33. PubMed ID: 27771352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of deep brain stimulation on substantia nigra neurons in a rat model of Parkinson's disease.
    Wu ST; Ma Y; Zhang K; Zhang JG
    Chin Med J (Engl); 2012 Nov; 125(22):4072-5. PubMed ID: 23158145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse.
    Regoni M; Zanetti L; Comai S; Mercatelli D; Novello S; Albanese F; Croci L; Consalez GG; Ciammola A; Valtorta F; Morari M; Sassone J
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34063112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-Dose Aspirin Upregulates Tyrosine Hydroxylase and Increases Dopamine Production in Dopaminergic Neurons: Implications for Parkinson's Disease.
    Rangasamy SB; Dasarathi S; Pahan P; Jana M; Pahan K
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):173-187. PubMed ID: 30187283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study.
    Blesa J; Pifl C; Sánchez-González MA; Juri C; García-Cabezas MA; Adánez R; Iglesias E; Collantes M; Peñuelas I; Sánchez-Hernández JJ; Rodríguez-Oroz MC; Avendaño C; Hornykiewicz O; Cavada C; Obeso JA
    Neurobiol Dis; 2012 Oct; 48(1):79-91. PubMed ID: 22677034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential interaction of competitive NMDA and AMPA antagonists with selective dopamine D-1 and D-2 agonists in a rat model of Parkinson's disease.
    Löschmann PA; Wüllner U; Heneka MT; Schulz JB; Kunow M; Wachtel H; Klockgether T
    Synapse; 1997 Aug; 26(4):381-91. PubMed ID: 9215597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine oxidation facilitates rotenone-dependent potentiation of N-methyl-D-aspartate currents in rat substantia nigra dopamine neurons.
    Wu YN; Johnson SW
    Neuroscience; 2011 Nov; 195():138-44. PubMed ID: 21884756
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P; Mercuri NB; Sancesario G; Bernardi G
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant somatic calcium channel function in cNurr1 and LRRK2-G2019S mice.
    Skiteva O; Yao N; Mantas I; Zhang X; Perlmann T; Svenningsson P; Chergui K
    NPJ Parkinsons Dis; 2023 Apr; 9(1):56. PubMed ID: 37029193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.